Amisulpride
SIGMA/A2729 - ≥98% (HPLC)
Synonym: 4-
CAS Number: 71675-85-9
Empirical Formula (Hill Notation): C17H27N3O4S
Molecular Weight: 369.48
EC Number: 275-831-7
MDL Number: MFCD00866691
Linear Formula: C17H27N3O4S
Product Type: Chemical
assay | ≥98% (HPLC) |
color | white |
form | powder |
InChI | 1S/C17H27N3O4S/c1-4-20-8- |
InChI key | NTJOBXMMWNYJFB-UHFFFAOYSA |
originator | Sanofi Aventis |
Quality Level | 100 |
SMILES string | O=C(NCC1CCCN1CC)C2=CC(S(= |
storage condition | desiccated |
protect from light | |
storage temp. | 2-8°C |
Application: | Amisulpride has been used as a dopamine receptor inhibitor to study its effects on diabetic bone abnormalities in mice. |
Biochem/physiol Actions: | Amisulpride is a highly selective D2/D3 dopamine receptor antagonist and atypical antipsychotic. |
Biochem/physiol Actions: | Amisulpride is a substituted benzamide derivative. It has a higher affinity towards dopamine receptors in limbic structures than the striatal structures. Amisulpride has a therapeutic effect against schizophrenia. |
Features and Benefits: | This compound was developed by Sanofi Aventis . To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here . |
Packaging: | 10, 50 mg in glass bottle |
Symbol | GHS07 |
Signal word | Warning |
Hazard statements | H302 |
Precautionary statements | P301 + P312 + P330 |
Hazard Codes | Xn |
Risk Statements | 22 |
Safety Statements | 22-24/25 |
RIDADR | NONH for all modes of transport |
WGK Germany | WGK 3 |
Flash Point(F) | Not applicable |
Flash Point(C) | Not applicable |
Purity | ≥98% (HPLC) |
Storage Temp. | 2-8°C |
UNSPSC | 12352200 |